Hiroki Takashima

7PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersAcceleratorsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 28, 2026
Potent antitumor efficacy of datopotamab deruxtecan compared with sacituzumab govitecan in an intracranial tumor model of triple-negative breast cancer.

|Mar 01, 2026
Attenuated Toxicity and Antitoxic Mechanism via Sodium Iodide Symporter Inhibition-Based Tumor-Selective Delivery in Astatine-211 Radioimmunotherapy.

Hiroki Takashima, Ryo Tsumura, Yoshikatsu Koga

|Sep 25, 2024
Anti-tissue factor antibody conjugated with monomethyl auristatin E or deruxtecan in pancreatic cancer models.

Ryo Tsumura, Takahiro Anzai, Yoshikatsu Koga

|May 14, 2023
Chromatographic Analysis of the N-Glycan Profile on Therapeutic Antibodies Using FcγRIIIa Affinity Column Chromatography.

Methanee Hiranyakorn, Shogo Iwamoto, Asako Hoshinoo

|Dec 27, 2022
Tumor Targeting of 211At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis.

Hiroki Takashima, Kazunobu Ohnuki, Shino Manabe

|Jun 06, 2022
Protection from contamination by 211At, an enigmatic but promising alpha-particle-emitting radionuclide.

Kazunobu Ohnuki, Mitsuyoshi Yoshimoto, Hiromitsu Haba

Pageof 2

Frequent Collaborators

7 joint publications

Masahiro Yasunaga

5 joint publications

Shino Manabe

2 joint publications

Yoshikatsu Koga

2 joint publications

Ryo Tsumura